High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea

Antimicrob Agents Chemother. 2005 Dec;49(12):5176-8. doi: 10.1128/AAC.49.12.5176-5178.2005.

Abstract

We tested the in vitro susceptibilities of 603 enterococcal isolates from eight tertiary-care hospitals in Korea. The quinupristin-dalfopristin resistance rate in Enterococcus faecium was very high (25 isolates, 10.0%). It was suggested that both clonal spread and the sporadic emergence of quinupristin-dalfopristin-resistant isolates may explain the high prevalence of quinupristin-dalfopristin resistance in Korea.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Microbial
  • Drug Resistance, Multiple / physiology*
  • Enterococcus faecium / drug effects*
  • Humans
  • Korea / epidemiology
  • Virginiamycin / analogs & derivatives*
  • Virginiamycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Virginiamycin
  • quinupristin-dalfopristin